Update on donor-derived infections in liver transplantation

Ignacio A. Echenique, Michael G. Ison*

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

11 Scopus citations


Advances in surgical techniques, immunosuppressive medications, and robust infectious disease prophylaxis have resulted in liver transplantation becoming the treatment of choice for patients with end-stage liver disease and unresectable hepatocellular carcinoma. Nonetheless, organ transplantation is not without risk. Unexpected donor-derived disease transmission is a newly recognized risk that complicates approximately 0.2% of all organ transplants. We review the epidemiology of donor-derived infectious diseases and methods of risk mitigation with a focus on liver transplantation. Liver Transpl 19:575-585, 2013. © 2013 AASLD.

Original languageEnglish (US)
Pages (from-to)575-585
Number of pages11
JournalLiver Transplantation
Issue number6
StatePublished - Jun 2013

ASJC Scopus subject areas

  • Surgery
  • Hepatology
  • Transplantation


Dive into the research topics of 'Update on donor-derived infections in liver transplantation'. Together they form a unique fingerprint.

Cite this